Skip to main content
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel

HJLI Insider Trading (Hancock Jaffe Laboratories)

Insider Ownership Percentage: 4.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $583,498.32

Hancock Jaffe Laboratories Insider Trading History Chart

Hancock Jaffe Laboratories Share Price & Price History

$5.12
▲ +0.1 (1.99%)
As of 05/14/2021 01:00 AM ET
Days: 30 | 90 | 365
30 Days of MarketBeat All Access for $1.00
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more.
Start Your Risk-Free Trial Here

Hancock Jaffe Laboratories Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/20/2020Holding S.A. BiodyneMajor ShareholderSell75,000$0.27$20,250.003,255,433View SEC Filing Icon  
8/18/2020Holding S.A. BiodyneMajor ShareholderSell50,000$0.34$17,000.003,255,433View SEC Filing Icon  
8/14/2020Holding S.A. BiodyneMajor ShareholderSell50,000$0.31$15,500.003,255,433View SEC Filing Icon  
8/3/2020Holding S.A. BiodyneMajor ShareholderSell70,000$0.32$22,400.003,255,433View SEC Filing Icon  
7/30/2020Holding S.A. BiodyneMajor ShareholderSell25,000$0.32$8,000.003,255,433View SEC Filing Icon  
7/20/2020Holding S.A. BiodyneMajor ShareholderSell150,000$0.43$64,500.003,255,433View SEC Filing Icon  
7/16/2020Holding S.A. BiodyneMajor ShareholderSell50,000$0.38$19,000.003,255,433View SEC Filing Icon  
7/6/2020Holding S.A. BiodyneMajor ShareholderSell6,450$0.39$2,515.503,255,433View SEC Filing Icon  
7/1/2020Holding S.A. BiodyneMajor ShareholderSell45,000$0.38$17,100.003,255,433View SEC Filing Icon  
6/29/2020Holding S.A. BiodyneMajor ShareholderSell68,094$0.39$26,556.663,255,433View SEC Filing Icon  
6/26/2020Holding S.A. BiodyneMajor ShareholderSell80,000$0.38$30,400.003,255,433View SEC Filing Icon  
6/24/2020Holding S.A. BiodyneMajor ShareholderSell55,530$0.42$23,322.603,255,433View SEC Filing Icon  
6/22/2020Holding S.A. BiodyneMajor ShareholderSell63,186$0.46$29,065.563,255,433View SEC Filing Icon  
6/19/2020Holding S.A. BiodyneMajor ShareholderSell80,000$0.46$36,800.003,255,433View SEC Filing Icon  
6/17/2020Holding S.A. BiodyneMajor ShareholderSell203,100$0.48$97,488.003,255,433View SEC Filing Icon  
6/15/2020Holding S.A. BiodyneMajor ShareholderSell100,000$0.42$42,000.003,255,433View SEC Filing Icon  
6/11/2020Holding S.A. BiodyneMajor ShareholderSell100,000$0.39$39,000.003,255,433View SEC Filing Icon  
6/2/2020Holding S.A. BiodyneMajor ShareholderSell220,000$0.33$72,600.003,361,016View SEC Filing Icon  
3/12/2019Robert Andrew BermanCEOBuy21,740$1.15$25,001.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Hancock Jaffe Laboratories (NASDAQ:HJLI)

10.14% of Hancock Jaffe Laboratories stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Hancock Jaffe Laboratories Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2021Dimensional Fund Advisors LP10,821$72K0.0%N/A0.127%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp15,360$0.10M0.0%N/A0.181%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC36,268$0.24M0.0%N/A0.426%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG17,061$0.11M0.0%+1,326.5%0.201%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC26,107$0.23M0.0%N/A1.008%Search for SEC Filing on Google Icon
2/14/2020Jane Street Group LLC112,263$62K0.0%-16.0%0.626%Search for SEC Filing on Google Icon
8/15/2019Jane Street Group LLC77,915$81K0.0%N/A0.435%Search for SEC Filing on Google Icon
2/15/2019Jane Street Group LLC31,692$47K0.0%N/A0.270%Search for SEC Filing on Google Icon
12/13/2018Vanguard Group Inc52,720$0.14M0.0%N/A0.450%Search for SEC Filing on Google Icon
11/23/2018Vanguard Group Inc.52,720$0.14M0.0%N/A0.450%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Hancock Jaffe Laboratories logo
Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA.
Read More on Hancock Jaffe Laboratories

Today's Range

Now: $5.12
$5.03
$5.30

50 Day Range

MA: $6.29
$5.02
$7.15

52 Week Range

Now: $5.12
$4.99
$20.25

Volume

72,403 shs

Average Volume

495,162 shs

Market Capitalization

$43.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58

Who are the company insiders with the largest holdings of Hancock Jaffe Laboratories?

Hancock Jaffe Laboratories' top insider investors include:
  1. Holding SA Biodyne (Major Shareholder)

Who are the major institutional investors of Hancock Jaffe Laboratories?

Hancock Jaffe Laboratories' top institutional investors include:
  1. Geode Capital Management LLC — 0.43%
  2. UBS Group AG — 0.20%
  3. Northern Trust Corp — 0.18%
  4. Dimensional Fund Advisors LP — 0.13%

Which institutional investors are buying Hancock Jaffe Laboratories stock?

During the last quarter, HJLI stock was purchased by institutional investors including:
  1. Geode Capital Management LLC
  2. UBS Group AG
  3. Northern Trust Corp
  4. Dimensional Fund Advisors LP
30 Days of MarketBeat All Access for $1.00
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more.
Start Your Risk-Free Trial Here